These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4987302)

  • 21. [Use of epsilon aminocaproic acid in abnormal hemorrhage using intrauterine contraceptive devices].
    Rueda González R
    Rev Colomb Obstet Ginecol; 1969; 20(4):273-8. PubMed ID: 5356119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preliminary report of a trial of a long acting antihistaminic, buclizine hydrochloride in patients with bleeding after insertion of an intrauterine device.
    Bedi P; Devi PK; Chaudhury RR
    Indian J Med Res; 1968 Jun; 56(6):884. PubMed ID: 4386522
    [No Abstract]   [Full Text] [Related]  

  • 23. [Histomorphological findings on the palatine tonsil after administration of adrenochrome semicarbazone sulfonic ester].
    Galletti C; Antonuccio C; Germanà G; Passantino G
    Boll Mal Orecch Gola Naso; 1969; 87(3):220-30. PubMed ID: 5381640
    [No Abstract]   [Full Text] [Related]  

  • 24. The effect of the levonorgestrel intrauterine system on uterine artery blood flow 1 year after insertion.
    Haberal A; Kayikcioglu F; Gunes M; Kaplan M; Ozdegirmenci O
    Ultrasound Obstet Gynecol; 2006 Mar; 27(3):316-9. PubMed ID: 16450358
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Use of oxytocics in the control of hemorrhages after the insertion of intrauterine devices].
    Marques Mde M; Rodrigues W; Arkader J
    Hospital (Rio J); 1970 Jul; 78(1):177-89. PubMed ID: 5312438
    [No Abstract]   [Full Text] [Related]  

  • 26. Noncontraceptive applications of the levonorgestrel intrauterine system.
    Jensen JT
    Curr Womens Health Rep; 2002 Dec; 2(6):417-22. PubMed ID: 12429074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies on uterine flushings in the baboon. I. Method of collection, cellular composition, and protein electrophoretic profiles in animals with and without intrauterine contraceptive devices.
    Peplow V; Breed WG; Jones CM; Eckstein P
    Am J Obstet Gynecol; 1973 Jul; 116(6):771-9. PubMed ID: 4197693
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of an intrauterine contraceptive device on uterine motility in the rat.
    Marcus SL; Marcus CC; Wilson KH
    Obstet Gynecol; 1966 Feb; 27(2):238-42. PubMed ID: 5909542
    [No Abstract]   [Full Text] [Related]  

  • 29. [Insertion and supervision of an intrauterine device].
    Ravina JH
    Presse Med (1893); 1970 Jan; 78(1):31-2. PubMed ID: 5436757
    [No Abstract]   [Full Text] [Related]  

  • 30. Should endometrial hyperplasia be regarded as a reason for abnormal uterine bleeding in users of the intrauterine contraceptive device?
    Ozalp S; Kabukcuoglu S; Tanir HM
    Eur J Contracept Reprod Health Care; 2003 Mar; 8(1):17-20. PubMed ID: 12725671
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of adrenaline and adrenoxyl on the content of coenzyme acylation in some organs in albino rats].
    Shebeko GS
    Ukr Biokhim Zh; 1970; 42(5):596-9. PubMed ID: 5511475
    [No Abstract]   [Full Text] [Related]  

  • 32. [Treatment of dysfunctional uterine hemorrhages by the intrauterine administration of a 10 per cent solution of aminocaprioc acid].
    Davygora LK
    Pediatr Akus Ginekol; 1974; (1):51-4. PubMed ID: 4457801
    [No Abstract]   [Full Text] [Related]  

  • 33. [A case of intolerance to a contraceptive intrauterine device].
    Konieczny A
    Wiad Lek; 1983 Dec; 36(23):1995-8. PubMed ID: 6675310
    [No Abstract]   [Full Text] [Related]  

  • 34. [The effect of catecholamines and their oxidation products on the tissue concentration of coenzyme A in in vivo and in vitro experiments].
    Shebeko GS
    Probl Endokrinol (Mosk); 1971; 17(6):81-4. PubMed ID: 5148152
    [No Abstract]   [Full Text] [Related]  

  • 35. [The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years)].
    Imperato F; Perniola G; Mossa B; Marziani R; Perniola F; Stragapede B; Napolitano C
    Minerva Ginecol; 2002 Jun; 54(3):271-8. PubMed ID: 12063443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Our experiences with the use of adrenochrome monosemicarbazone in surgery].
    Quarta AN; Bimonte D
    Acta Anaesthesiol; 1967; 18(6):955-63. PubMed ID: 5633207
    [No Abstract]   [Full Text] [Related]  

  • 37. Dysfunctional uterine bleeding.
    Farrell E
    Aust Fam Physician; 2004 Nov; 33(11):906-8. PubMed ID: 15584330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Medical treatment of idiopathic menorrhagia].
    Graesslin O; Derniaux E
    J Gynecol Obstet Biol Reprod (Paris); 2008 Dec; 37 Suppl 8():S384-97. PubMed ID: 19268217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in the ultrastructure and number of platelets induced by an adrenochrome complex.
    Stewart GJ
    Thromb Diath Haemorrh; 1970 May; 23(2):237-60. PubMed ID: 4316663
    [No Abstract]   [Full Text] [Related]  

  • 40. Treatment of dysfunctional uterine bleeding: patient preferences for endometrial ablation, a levonorgestrel-releasing intrauterine device, or hysterectomy.
    Bourdrez P; Bongers MY; Mol BW
    Fertil Steril; 2004 Jul; 82(1):160-6, quiz 265. PubMed ID: 15237006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.